Laxmi Dental Fair Value
Laxmi Dental (LAXMIDENTL) average fair value is ₹330.5 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹205.15 (+61.1%), fair value range ₹27.18–₹1018.45. For live price and a broader fundamental view, visit Laxmi Dental stock price NSE .
Fair Value Analysis Export
LAXMIDENTL Fair Value vs Current Price — Valuation Summary
LAXMIDENTL average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). Explore LAXMIDENTL investment value to estimate fundamental worth using multiple valuation models.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
LAXMIDENTL Fair Value Analysis — Data Sources & Coverage
Laxmi Dental financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. Examine LAXMIDENTL quarterly trends for recent quarterly revenue, profit and EPS trends.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
LAXMIDENTL vs Healthcare Sector Peers — P/E, P/B & Market Cap
Laxmi Dental P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Accretion Pharmaceuticals | ACCPL | 14.17 | 2.14 | ₹100 |
| Jeena Sikho Lifecare | JSLL | 41.45 | 23.68 | ₹8,396 |
| Par Drugs & Chemical | PAR | 8.21 | 1.07 | ₹114 |
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| KRM Ayurveda | KRMAYURVED | - | 3.9 | ₹474 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.